Published date: 11 March 2019

Last edited date: 11 March 2019

This notice was replaced on 25 July 2019

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Awarded contract (published 25 July 2019)

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Contract summary

Industry

  • Diagnostic agents - 33694000

Location of contract

Any region, Scotland, Wales, Northern Ireland, Isle of Man, Channel Islands

Value of contract

£0

Procurement reference

CM/PHV/16/5512

Published date

11 March 2019

Closing date

10 April 2019

Contract start date

1 April 2020

Contract end date

31 March 2022

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

The provision of tuberculin purified protein derivative (PPD) to be used as part of the national immunisation programme. The contracting authority estimates their requirement over the period
of the contract, including the period of the optional extension to be up to 17,055 packs of product.
Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.

More information

Previous notice about this procurement

Tuberculin Purified Protein Derivative (PPD) (04-2020)

  • Future opportunity
  • Published 15 August 2017, last edited 15 August 2017

Attachments

About the buyer

Address

Department of Health
2nd Floor, Rutland House
Runcorn, cheshire
WA7 2ES
England

Email

alan.white@dhsc.gsi.gov.uk